Cargando…

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

BACKGROUND: The objective was to assess the response rate and survival of patients with metastatic mucosal melanoma (MM) and uveal melanoma (UM) treated with anti-CTLA-4 or anti-PD-1 monoclonal antibodies (mAbs). METHODS: A multicenter retrospective study was performed in 25 dermatology departments...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mignard, Claire, Deschamps Huvier, Aurélie, Gillibert, André, Duval Modeste, Anne Bénédicte, Dutriaux, Caroline, Khammari, Amir, Avril, Marie-Françoise, Kramkimel, Nora, Mortier, Laurent, Marcant, Pierre, Lesimple, Thierry, Gaudy-Marqueste, Caroline, Lesage, Candice, Machet, Laurent, Aubin, François, Meyer, Nicolas, Beneton, Nathalie, Jeudy, Géraldine, Montaudié, Henri, Arnault, Jean-Philippe, Visseaux, Laetitia, Trabelsi, Sabiha, Amini-Adle, Mona, Maubec, Eve, Le Corre, Yannick, Lipsker, Dan, Wierzbicka-Hainaut, Ewa, Litrowski, Noémie, Stefan, Andreea, Brunet-Possenti, Florence, Leccia, Marie-Thérèse, Joly, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304636/ https://www.ncbi.nlm.nih.gov/pubmed/30631354 http://dx.doi.org/10.1155/2018/1908065

Ejemplares similares

La pandémie COVID-19 est associée à des mélanomes diagnostiqués à un stade plus avancé
por: Skowron, F., et al.
Publicado: (2022)

Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
por: Huynh, Sandra, et al.
Publicado: (2020)

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
por: Becquart, Ondine, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
por: Kandel, Marguerite, et al.
Publicado: (2022)

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
por: Russo, David, et al.
Publicado: (2023)

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study
por: Montaudié, Henri, et al.
Publicado: (2020)

Que retenir de notre expérience d’enseignement « virtuel » au cours de la période épidémique? Enquête nationale du CEDEF auprès des enseignants et des internes de dermatologie
por: Samimi, Mahtab, et al.
Publicado: (2021)

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
por: Poinas, Alexandra, et al.
Publicado: (2020)

Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
por: Reichert, Constance, et al.
Publicado: (2023)

Necrotic ulcerated and bleeding striae distensae following bevacizumab in a palliative setting for gliobastomatosis cerebri
por: Laugier, Olivia, et al.
Publicado: (2017)

Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population
por: Malissen, Nausicaa, et al.
Publicado: (2021)

Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey
por: Samaran, Quentin, et al.
Publicado: (2022)

Impact of STROBE Statement Publication on Quality of Observational Study Reporting: Interrupted Time Series versus Before-After Analysis
por: Bastuji-Garin, Sylvie, et al.
Publicado: (2013)

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
por: Hober, Candice, et al.
Publicado: (2021)

Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision
por: Hartung, Niklas, et al.
Publicado: (2017)

Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer
por: Gouton, Etienne, et al.
Publicado: (2022)

Early Phase of Primary Melanoma Growth from the Patient Point of View: A Prospective Cross Sectional Study on Melanoma over 1 mm in Thickness
por: MALISSEN, Nausicaa, et al.
Publicado: (2020)

A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule
por: Nollet, Marie, et al.
Publicado: (2017)

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014)

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
por: Pinard, Camille, et al.
Publicado: (2017)

COVID-19 : adhésion à la vaccination chez des patients immunodéprimés de dermatologie
por: Lafon, Audrey, et al.
Publicado: (2021)

The first large-scale All Taxa Biodiversity Inventory in Europe: description of the Mercantour National Park ATBI datasets
por: Ichter, Jean, et al.
Publicado: (2022)

BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
por: Frazao, Alexandra, et al.
Publicado: (2020)

Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis
por: Benyahia, Zohra, et al.
Publicado: (2022)

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
por: Gondois-Rey, Françoise, et al.
Publicado: (2021)

A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells
por: Aspord, Caroline, et al.
Publicado: (2010)

Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature
por: Vuillamy, Chloé, et al.
Publicado: (2023)

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma
por: Malissen, Nausicaa, et al.
Publicado: (2019)

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma
por: Hauschild, Axel, et al.
Publicado: (2018)

Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial
por: Marcé, Diane, et al.
Publicado: (2022)

Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?
por: Brousse, Valentine, et al.
Publicado: (2021)

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
por: Busser, Benoit, et al.
Publicado: (2017)

SARS-CoV-2 infection in patients with β-thalassemia: The French experience
por: Jean-Mignard, Estelle, et al.
Publicado: (2022)

Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!
por: Luherne, Camille, et al.
Publicado: (2019)

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover
por: Lebbé, Celeste, et al.
Publicado: (2020)

Prévalence de COVID-19 chez le personnel du chu de Lille
por: Wardyn, Pierre-Marie, et al.
Publicado: (2022)

Histoire de mots : culture et civilisation /
por: Bénéton, Philippe
Publicado: (1975)

The Schnitzler syndrome
por: Lipsker, Dan
Publicado: (2010)

A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?
por: Lipsker, Dan
Publicado: (2020)

Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
por: Lipsker, Dan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_33rvqhpe49mnropt5etpf47ugj